Active Clinical Trials

Diabetic Retinopathy and Diabetic Macular Edema Protocol W:


Intravitreous Anti-VEGF Treatment for Prevention of Vision                                Threatening Diabetic Retinopathy in Eyes at High Risk

       Status: Enrolled Protocol AC:


Randomized Trial of Intravitreous Aflibercept versus Intravitreous  Bevacizumab + Deferred Afliberceptf or Treatment of Central-Involved Diabetic Macular Edema

       Status: Actively enrolling


Age-Related Macular Degeneration

   Dry Macular Degeneration:

Phase III , Multi-Center, Randomized, Double-Masked, Sham –Controlled study to compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections In Patients with Geographic Atrophy secondary to Age-Related Macular Degeneration. 

Status: Anticipated start in October, 2018

  Wet Macular Degeneration:


GBV-102, long-acting depot therapy for neovascular age-related macular  degeneration.

Status: Anticipated start in early 2019


Mid Atlantic Retina Specialists  is a retina practice in Maryland and Pennsylvania, delivering state-of-the-art, comprehensive patient care. Our practice is dedicated to the diagnosis and treatment of retina, vitreous and macula disorders, with the goal of improving the quality of life of our patients.

World-Renowned Retina Surgeons. All of our doctors are fellowship trained at outstanding institutions.

Attention-to-Detail for Treatment & Surgery. Our physicians utilize the most advanced therapies and surgical approaches, combined with an unfailing attention to consistency and detail, to provide the best treatment available.

Cutting Edge Technology. All of our offices have the latest diagnostic and therapeutic services. We Keep Our Patients Informed - by providing information on common diseases in print and on our website.

Easily Accessible Offices. Our offices are easy to find, with multiple locations.


To Schedule An Appointment

Call 301-671-2400​